These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 21560153)

  • 21. Is the bladder a reliable witness for predicting detrusor overactivity?
    Hashim H; Abrams P
    J Urol; 2006 Jan; 175(1):191-4; discussion 194-5. PubMed ID: 16406907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes.
    Lin TL; Chen GD; Chen YC; Huang CN; Ng SC
    Taiwan J Obstet Gynecol; 2012 Sep; 51(3):381-6. PubMed ID: 23040921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
    Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.
    Bael A; Lax H; de Jong TP; Hoebeke P; Nijman RJ; Sixt R; Verhulst J; Hirche H; van Gool JD;
    J Urol; 2008 Oct; 180(4):1486-93; discussion 1494-5. PubMed ID: 18710726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
    Jiménez-Cidre MA; López-Fando L; Mora AM;
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of bladder sensation measures and bladder diary in patients with urinary incontinence.
    King AB; Wolters JP; Klausner AP; Rapp DE
    Can J Urol; 2012 Apr; 19(2):6183-7. PubMed ID: 22512963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overactive bladder is not only overactive but also hypersensitive.
    Lee SR; Kim HJ; Kim A; Kim JH
    Urology; 2010 May; 75(5):1053-9. PubMed ID: 20092879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the Overactive Bladder Symptom Score, and the Voiding Diary and Urodynamic Parameters in Patients with Overactive Bladder Syndrome.
    Song M; Chun JY; Yoo DS; Han JY; Choo MS
    Low Urin Tract Symptoms; 2014 Sep; 6(3):180-4. PubMed ID: 26663602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations relating to urinary sensation during detrusor overactivity.
    Lowenstein L; Pham T; Abbasy S; Kenton K; Brubaker L; Mueller ER; Shott S; Vardi Y; Gruenwald I; FitzGerald MP
    Neurourol Urodyn; 2009; 28(6):497-500. PubMed ID: 19090593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of urodynamic characteristics between female patients with overactive bladder and overactive bladder plus stress urinary incontinence.
    Lin LY; Yeh NH; Lin CY; Sheu BC; Lin HH
    Urology; 2004 Nov; 64(5):945-9. PubMed ID: 15533483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urodynamic findings in young men with chronic lower urinary tract symptoms.
    Karami H; Valipour R; Lotfi B; Mokhtarpour H; Razi A
    Neurourol Urodyn; 2011 Nov; 30(8):1580-5. PubMed ID: 21780163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units?
    Esteban-Fuertes M; Prieto-Chaparro L; Arlandis-Guzmán S; Salinas-Casado J; Gago-Ramos JL;
    Actas Urol Esp (Engl Ed); 2022; 46(1):41-48. PubMed ID: 34848162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urodynamic findings in female diabetic patients with and without overactive bladder symptoms.
    Ho CH; Tai HC; Yu HJ
    Neurourol Urodyn; 2010 Mar; 29(3):424-7. PubMed ID: 19283863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urodynamic diagnoses and quality of life in women presenting for evaluation of urinary incontinence.
    Duggan P
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):416-20. PubMed ID: 21810086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
    BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of urodynamic parameters in patients with overactive bladder.
    Frenkl TL; Railkar R; Palcza J; Scott BB; Alon A; Green S; Schaefer W
    Neurourol Urodyn; 2011 Nov; 30(8):1565-9. PubMed ID: 21674594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.